UK London Duchen MR: Difference between revisions
From Bioblast
No edit summary |
No edit summary Β |
||
(8 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{ | {{O2k-Network Lab | ||
|institution=Department of Physiology | |institution=Department of Physiology | ||
Line 6: | Line 6: | ||
|country=United Kingdom | |country=United Kingdom | ||
|weblink=[[UCL Consortium for Mitochondrial Research]] | |weblink=[[UCL Consortium for Mitochondrial Research]] | ||
|Contact=Duchen | |Contact=Duchen Michael R | ||
|MiPNetLab=Kotiadis | |MiPNetLab=Briston Thomas, Kotiadis Will, Stanzani Giacomo | ||
|Status=O2k 2012- | |Status=O2k 2012- | ||
|info=[[Bioblast 2012]] | |info=[[MiPNet23.03 IOC128 Cambridge UK| IOC128]], organizer of [[MiPschool_London_2015| MiPschool 2015]], [[Bioblast 2012 | Bioblast 2012]] | ||
}} | }} |
Latest revision as of 09:21, 2 August 2019
UK London Duchen MR
O2k-Network Lab | Department of Physiology
University College London |
---|---|
Address | , |
City | London |
State/Prov | |
Country | United Kingdom |
Weblink | UCL Consortium for Mitochondrial Research |
Contact | Duchen Michael R |
Team | Briston Thomas, Kotiadis Will, Stanzani Giacomo |
Team previous | |
Status | O2k 2012- |
Oroboros Events | IOC128, organizer of MiPschool 2015, Bioblast 2012 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Saura-Esteller 2021 Int J Mol Sci | 2021 | Saura-Esteller J, SΓ‘nchez-Vera I, NΓΊΓ±ez-VΓ‘zquez S, Cosialls AM, Gama-PΓ©rez P, Bhosale G, Mendive-Tapia L, Lavilla R, Pons G, Garcia-Roves PM, Duchen MR, Iglesias-Serret D, Gil J (2021) Activation of the integrated stress response and ER stress protect from fluorizoline-induced apoptosis in HEK293T and U2OS cell lines. Int J Mol Sci 22:6117. |
Connolly 2018 Cell Death Differ | 2018 | Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, BolaΓ±os JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, DΓΌssmann H, Fiskum G, Galindo MF, Hardingham GE, Hardwick JM, Jekabsons MB, Jonas EA, JordΓ‘n J, Lipton SA, Manfredi G, Mattson MP, McLaughlin B, Methner A, Murphy AN, Murphy MP, Nicholls DG, Polster BM, Pozzan T, Rizzuto R, SatrΓΊstegui J, Slack RS, Swanson RA, Swerdlow RH, Will Y, Ying Z, Joselin A, Gioran A, Moreira Pinho C, Watters O, Salvucci M, Llorente-Folch I, Park DS, Bano D, Ankarcrona M, Pizzo P, Prehn JHM (2018) Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ 25:542-72. https://doi.org/10.1038/s41418-017-0020-4 |
Corrochano 2018 Hum Mol Genet | 2018 | Corrochano S, Blanco G, Williams D, Wettstein J, Simon M, Kumar S, Moir L, Agnew T, Stewart M, Landman A, Kotiadis VN, Duchen MR, Wackerhage H, Rubinsztein DC, Brown SDM, Acevedo-Arozena A (2018) A genetic modifier suggests that endurance exercise exacerbates Huntington's disease. Hum Mol Genet 27:1723-31. |
Briston 2017 Sci Rep | 2017 | Briston T, Roberts M, Lewis S, Powney B, M Staddon J, Szabadkai G, Duchen MR (2017) Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability. Sci Rep 7:10492. |
Selwood 2017 US Patent | 2017 | Selwood DL, Baker D, Szabadkai G, Duchen MR, Hill JM, Warne JND (2017) Quinolium conjugates of cyclosporin. US Patent US20170349632 A1. |
Briston 2016 Sci Rep | 2016 | Briston T, Lewis S, Koglin M, Mistry K, Shen Y, Hartopp N, Katsumata R, Fukumoto H, Duchen MR, Szabadkai G, Staddon JM, Roberts M, Powney B (2016) Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria. Sci Rep 6:37798. |
MiPNet20.03 IOC101 London | 2015-04-21 | London UK, 2015 Apr 21-23. Oroboros O2k-Workshop on HRR and O2k-Fluorometry, IOC101. |
Warne 2015 J Biol Chem | 2015 | Warne J, Pryce G, Hill JM, Shi X, LennerΓ₯s F, Puentes F, Kip M, Hilditch L, Walker P, Simone MI, Chan AWE, Towers GJ, Coker AR, Duchen MR, Szabadkai G, Baker D, Selwood DL (2015) Selective inhibition of the mitochondrial permeability transition pore protects against neuro-degeneration in experimental multiple sclerosis. J Biol Chem 291:4356-73. |
Corona 2014 Exp Neurol | 2014 | Corona JC, de Souza SC, Duchen MR (2014) PPARΞ³ activation rescues mitochondrial function from inhibition of 2 complex I and loss of PINK1. Exp Neurol 253:16-27. |
Logan 2014 Nat Genet | 2014 | Logan CV, Szabadkai G, Sharpe JA, Parry DA, Torelli S, Childs AM, Kriek M, Phadke R, Johnson CA, Roberts NY, Bonthron DT, Pysden KA, Whyte T, Munteanu I, Foley AR, Wheway G, Szymanska K, Natarajan S, Abdelhamed ZA, Morgan JE, Roper H, Santen GW, Niks EH, van der Pol WL, Lindhout D, Raffaello A, De Stefani D, den Dunnen JT, Sun Y, Ginjaar I, Sewry CA, Hurles M, Rizzuto R. UK10K Consortium, Duchen MR, Muntoni F, Sheridan E (2014) Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat Genet 46:188-93. |
O2k-Abstracts
Published | Reference | |
---|---|---|
Logan 2015 Abstract MiPschool London 2015 | 2015 | Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signalling. |